![]() 968,407,850 visitors served. |
|
![]() Dictionary/ thesaurus | ![]() Medical dictionary | ![]() Legal dictionary | ![]() Financial dictionary | ![]() Acronyms | ![]() Idioms | ![]() Encyclopedia | ![]() Wikipedia encyclopedia | ? |
Immunotherapy |
Also found in: Wikipedia | 0.03 sec. |
|
immunotherapy /im·mu·no·ther·a·py/ (-ther´ah-pe) passive immunization of an individual by administration of preformed antibodies (serum or gamma globulin) actively produced in another individual; by extension, the term has come to include the use of immunopotentiators, replacement of immunocompetent lymphoid tissue (e.g., bone marrow or thymus), etc.
Immunotherapy A form of treatment that uses biologic agents to enhance or stimulate normal immune function. Mentioned in: Bladder Cancer, Hairy Cell Leukemia, Kidney Cancer, Leukemias, Chronic, Malignant Melanoma immunotherapy, n improving the performance of the body's immune system by using immunization and immune factors. See also isopathy. immunotherapy (im´ūnōther´ n a special treatment of allergic responses that administers increasingly large doses of the offending allergens to gradually develop immunity. immunotherapy passive immunization of an animal by administration of preformed antibodies (serum or gamma globulin) actively produced in another individual; by extension, the term has come to include the use of immunopotentiators, replacement of immunocompetent lymphoid tissue (e.g. bone marrow or thymus), etc. Because the immune response is a process of surveillance, recognition and attack of foreign cells, immunotherapy has emerged as a promising mode of treatment for cancer. Nonspecific immunotherapy relies on general immune stimulants to activate the whole immune system. In the past decade, immunotherapy against cancer has involved the use of the bacille Calmette-Guérin (BCG) vaccine (see bcg vaccine), which is evolved from strains of Mycobacterium tuberculosis, and is used to provide some immunity to tuberculosis. Recently, interferon has been considered as a good prospect for converting inactive immune cells into active 'natural killers' that attack tumor cells directly. See also hyposensitization. |
|
? Mentioned in | ? References in periodicals archive | ||
|---|---|---|---|
| We are very pleased to partner with AVANT Immunotherapeutics on the application of our VLP platform technology to this major commercial opportunity," said Martin Soust, Ph. com/reports/c49832) has announced the addition of "AVANT Immunotherapeutics Inc - Deals and Alliances Report" to their offering. Susanna Rybak, a member of Alfacell's Scientific Advisory Board, is an invited speaker at IBC Life Sciences' 17th Annual Conference on Antibody Engineering and Immunotherapeutics for the 21st Century, to be held December 10-14, 2006 in San Diego, CA. |
| Free Tools: |
For surfers:
Browser extension |
Word of the Day |
Help
For webmasters: Free content NEW! | Linking | Lookup box | Double-click lookup | Partner with us |
|
|---|